Keyphrases
Antiretroviral Therapy
100%
Standard of Care
100%
HIV RNA
100%
Susceptibility Testing
100%
Randomized Prospective Study
100%
Nucleoside Reverse Transcriptase Inhibitors
60%
Protease Inhibitors
60%
Antiretroviral Regimens
40%
Inhibitor Drug
40%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
40%
Clinically Significant
20%
CD4 Count
20%
Predictive Value
20%
Potential Gains
20%
Viral Suppression
20%
Virological Outcome
20%
Multicenter Cohort Study
20%
Resistant Virus
20%
Inhibitor Sensitivity
20%
Drug Inhibitors
20%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Antiretroviral Therapy
100%
Prospective Study
100%
Proteinase Inhibitor
60%
Reverse-Transcriptase Inhibitor
60%
Nonnucleoside Reverse Transcriptase Inhibitor
40%
Cell Count
20%
Virus
20%
Primary Outcome
20%
Nursing and Health Professions
Human Immunodeficiency Virus
100%
Antiretroviral Therapy
100%
Health Care Quality
100%
Proteinase Inhibitor
60%
RNA Directed DNA Polymerase Inhibitor
60%
Nonnucleoside Reverse Transcriptase Inhibitor
40%
CD4 Lymphocyte Count
20%
Predictive Value
20%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Reverse Transcriptase
100%
Ribonucleic Acid
100%
Susceptibility
100%
CD4 Lymphocyte Count
20%
Virus
20%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Prospective Study
100%
RNA Directed DNA Polymerase Inhibitor
60%
Proteinase Inhibitor
60%
Nonnucleoside Reverse Transcriptase Inhibitor
40%
Neuroscience
Human Immunodeficiency Virus
100%
Proteinase
60%
Reverse-Transcriptase Inhibitor
60%
Non-Nucleoside Reverse Transcriptase Inhibitors
40%
CD4
20%